Skip to content
11th September 2026

One Biosciences Presents Validation Data Supporting First Prospective Study of Real-Time Single-Cell Sequencing of Clinical FFPE Tumor Samples

10th September 2026

One Biosciences receives €3,3 Million funding under i-Démo 5 from France 2030 to Accelerate Development of First Single-Cell Diagnostic for Triple-Negative Breast Cancer, in Collaboration with Institut Curie

30th July 2026

One Biosciences Announces Data Validating New Method for Single-Cell Transcriptomic Tumor Profiling from Clinical Pathology Samples

22nd June 2026

One Biosciences receives BOOST funding from Paris-Saclay Cancer Cluster to advance the first single-cell assay approach for ADC therapies

6th June 2026

BiotechTV: Interview of One Biosciences CEO 

19th May 2026

GenomeWeb: Gustave Roussy, One Biosciences to predict cancer treatment response from single-cell analysis

19th May 2026

Gustave Roussy and One Biosciences partner to bring single cell to clinical practice for precision oncology.

24th April 2026

GEN: One Biosciences Chooses Albany, NY, as its U.S. Location

17th April 2026

Times Union: One Biosciences to open Albany location

17th April 2026

NEWS 10: From Paris to Albany: Biotech will bring jobs and leverage AI for cancer treatment

Top